Related references
Note: Only part of the references are listed.LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis
Zufeng Ding et al.
CARDIOVASCULAR RESEARCH (2014)
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
Qing Jiang
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Inflammation and Atherosclerosis-Revisited
Sadip Pant et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Regulatory metabolites of vitamin E and their putative relevance for atherogenesis
Maria Wallert et al.
REDOX BIOLOGY (2014)
α-Tocopherol induces proatherogenic changes to HDL2 & HDL3: An in vitro and ex vivo investigation
Lauren Wade et al.
ATHEROSCLEROSIS (2013)
Supplementation of a γ-tocopherol-rich mixture of tocopherols in healthy men protects against vascular endothelial dysfunction induced by postprandial hyperglycemia
Eunice Mah et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Reactive oxygen species in cardiovascular disease
Koichi Sugamura et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Gamma tocopherol supplementation prevents exercise induced coagulation and platelet aggregation
Lazarela Vucinic et al.
THROMBOSIS RESEARCH (2010)
Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
Victor M. Victor et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
γ-tocopherol supplementation alone and in combination with α-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome
Sridevi Devaraj et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Gamma-tocopherol may promote effective no synthase function by protecting tetrahydrobiopterin from peroxynitrite
Mark F. McCarty
MEDICAL HYPOTHESES (2007)
Scavenger receptors in atherosclerosis: Beyond lipid uptake
Kathryn J. Moore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease
J Himmelfarb et al.
KIDNEY INTERNATIONAL (2003)
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials
DP Vivekananthan et al.
LANCET (2003)
γ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats
Q Jiang et al.
FASEB JOURNAL (2003)
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression -: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study
RM Salonen et al.
CIRCULATION (2003)
γ-Tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation
Q Jiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Effect of mixed tocopherols on ecNOS, SOD and PKC in leukocytes in human subjects
ML Liu et al.
NUTRITION RESEARCH (2002)
Mixed Tocopherols have a stronger inhibitory effect on lipid peroxidation than α-tocopherol alone
ML Liu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
γ-tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells
Q Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
M Boaz et al.
LANCET (2000)
Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells
R Ricciarelli et al.
CIRCULATION (2000)
Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human corollary smooth muscle cells
F de Nigris et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Vitamin E supplementation and cardiovascular events in high-risk patients
S Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The relationship of oxidized lipids to coronary artery stenosis
FA Kummerow et al.
ATHEROSCLEROSIS (2000)
Share Paper
